研究業績
Achievement

2022年の研究業績

1. 原著

  1. Watanabe, S, Yuba, E, Akazawa T, Wijewardana V, Kakihara Y, Azuma A, Hagimori, K, Kanegi R, Hatoya S, Inoue N, Inaba T, Sugiura K. Potent adjuvant effect elicited for tumor immunotherapy by a liposome conjugated pH-sensitive polymer and dendritic cell-targeting Toll-like-receptor ligand. Vaccine. 2022 Mar 1; 40(10):1448-1457. doi: 10.1016/j.vaccine.2022.01.048. PMID: 35131134
  2. Kato, M., Kudo, Y., Hatase, M., Tsuchida, N., Takeyama, S., Sugiyama, T., Fujimura, M, Yabe, I, Tsujimoto, H., Fukumori, Y., Inoue, N., and Atsumi, T. Moyamoya Disease Associated with a Deficiency of Complement Component 6. J Stroke Cerebrovasc Dis. 2022 Aug 01; 31(8):106601.
  3. Katayama, K., Zheng, Y., Inoue, N. Rac-deficient cerebellar granule neurons die before they migrate to the internal granule layer. Scie Rep. 2022, 12(1):14848 doi: 10.1038/s41598-022-19252-y PMID: 36050459
  4. Fujimoto, K., Hashimoto, D., Kashimada, K., Kumegawa, S., Ueda, Y., Hyuga, T., Hirashima, T., Inoue, N., Suzuki, K., Hara, I., Asamura, S. and Yamada. G. A visualization system for erectile vascular-dynamics Front. Cell Dev. Biol. Oct 2022 14;10:1000342. doi: 10.3389/fcell.2022.1000342
  5. Ohashi T, Terazawa K, Shibata H, Inoue N, Ogawa T. Metabolic profiling analysis of head and neck squamous cell carcinoma. Oral Dis 2022, Nov 8. doi: 10.1111/odi.14432. 2024 Mar;30(2):342-352.
  6. Shichinohe N, Kobayashi D, Izumi A, Hatanaka K, Fujita R, Kinoshita T, Inoue N, Hamaue N, Wada K, Murakami Y. Sequential hydrolysis of FAD by ecto-5' nucleotidase CD73 and alkaline phosphatase is required for uptake of vitamin B(2) into cells. J Biol Chem 2022, 102640. doi: 10.1016/j.jbc.2022.102640.

2. 総説

英文

和文

  1. 井上徳光:自己炎症性疾患としての補体異常症 日本皮膚科学会雑誌 2022; 132(11): 2487-2493
  2. 井上徳光 木下タロウ:補体活性化とその制御 日本臨牀 月刊誌 特集 補体と疾患―いま補体がおもしろい― 2022; 80(11): 1706-1712
  3. 大谷克城、井上徳光、日高義彦、若宮伸隆:日本の補体検査の進展 日本臨牀 月刊誌特集 補体と疾患―いま補体がおもしろい― 2022; 80(11): 1820-1825
トップへ